company background image
2873 logo

Guiyang Xintian PharmaceuticalLtd SZSE:002873 Stock Report

Last Price

CN¥12.52

Market Cap

CN¥2.9b

7D

-2.9%

1Y

-12.3%

Updated

08 Apr, 2024

Data

Company Financials +

Guiyang Xintian Pharmaceutical Co.,Ltd.

SZSE:002873 Stock Report

Market Cap: CN¥2.9b

2873 Stock Overview

Guiyang Xintian Pharmaceutical Co.,Ltd. se dedica a la investigación y desarrollo, producción y venta de nuevos medicamentos chinos patentados para diversas enfermedades en China.

2873 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance2/6
Financial Health4/6
Dividends2/6

Guiyang Xintian Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guiyang Xintian PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥12.52
52 Week HighCN¥15.24
52 Week LowCN¥7.59
Beta-0.12
1 Month Change18.67%
3 Month Change3.47%
1 Year Change-12.32%
3 Year Change54.53%
5 Year Change31.58%
Change since IPO57.36%

Recent News & Updates

Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Mar 11
Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Recent updates

Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Mar 11
Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Shareholder Returns

2873CN PharmaceuticalsCN Market
7D-2.9%0.7%0.9%
1Y-12.3%-14.7%-16.5%

Rentabilidad frente al sector: 002873 superó al sector CN Pharmaceuticals , que obtuvo un rendimiento del -13% el año pasado.

Rentabilidad vs. Mercado: 002873 superó al mercado CN, que obtuvo un rendimiento del -12.6% el año pasado.

Price Volatility

Is 2873's price volatile compared to industry and market?
2873 volatility
2873 Average Weekly Movement9.7%
Pharmaceuticals Industry Average Movement7.2%
Market Average Movement8.3%
10% most volatile stocks in CN Market11.6%
10% least volatile stocks in CN Market5.2%

Precio estable de las acciones: 002873ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 002873 (3%) se ha mantenido estable durante el año pasado.

About the Company

FoundedEmployeesCEOWebsite
1995923Da Lun Donghttps://www.gyxtyy.com

Guiyang Xintian Pharmaceutical Co.,Ltd. se dedica a la investigación y desarrollo, producción y venta de nuevos medicamentos chinos patentados para diversas enfermedades en China. La empresa ofrece productos de formulación, que incluyen cápsulas duras, gránulos, comprimidos, mezclas, jarabes, licores, rocíos, polvos, suspensiones y geles.

Guiyang Xintian Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Guiyang Xintian PharmaceuticalLtd's earnings and revenue compare to its market cap?
2873 fundamental statistics
Market capCN¥2.88b
Earnings (TTM)CN¥98.93m
Revenue (TTM)CN¥994.10m

29.1x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2873 income statement (TTM)
RevenueCN¥994.10m
Cost of RevenueCN¥231.05m
Gross ProfitCN¥763.05m
Other ExpensesCN¥664.13m
EarningsCN¥98.93m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 12, 2024

Earnings per share (EPS)0.43
Gross Margin76.76%
Net Profit Margin9.95%
Debt/Equity Ratio55.6%

How did 2873 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

23%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.